Literature DB >> 10226990

[Proliferative activity in recurrent and nonrecurrent pleomorphic adenoma of the salivary glands].

D G Bankamp1, E Bierhoff.   

Abstract

BACKGROUND: The origin of recurrences of pleomorphic adenomas after initial surgical treatment is discussed. In this study mesenchymal and epithelial tumorcomponents were immunhistochemically stained in recurrent and nonrecurrent adenoma. In addition the proliferation activity was assessed.
METHODS: Twelve nonrecurrent adenomas (10 of the parotid gland, 2 of the submandibular gland) and 18 recurrent adenomas (15 of the parotid gland, 3 of the submandibular gland) were immunhistochemically stained with a MIB1 antibody against the cell proliferation associated nuclear antigen (Ki-67 antigen). The proliferation index (MIB1 positive cells per 100 cells) was calculated separately for each tumor component.
RESULTS: The mean value (x) of the proliferation indices of the component with epithelial differentiation was 4.67 (recurrent group, standard deviation [SD]: 3.14) and x = 2.34 respectively (nonrecurrent group, SD = 1.83). The difference between the mean values was significant (p = 0.028). For the component with mesenchymal differentiation the values were x = 0.33 (for recurrent adenomas, SD = 0.59) and x = 0.17 (nonrecurrent adenomas, SD = 0.39) respectively. The difference was not significant.
CONCLUSIONS: Proliferation activity is markedly higher in components with epithelial differentiation of recurrent adenomas compared to nonrecurrent tumors. The results demonstrate the tumor component with epithelial differentiation as a possible origin for recurrence.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10226990     DOI: 10.1055/s-2007-996835

Source DB:  PubMed          Journal:  Laryngorhinootologie        ISSN: 0935-8943            Impact factor:   1.057


  4 in total

1.  Mucin expression in pleomorphic adenoma of salivary gland: a potential role for MUC1 as a marker to predict recurrence.

Authors:  T Hamada; S Matsukita; M Goto; S Kitajima; S K Batra; T Irimura; K Sueyoshi; K Sugihara; S Yonezawa
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

Review 2.  Why Do Parotid Pleomorphic Adenomas Recur? A Systematic Review of Pathological and Surgical Variables.

Authors:  Pavel Dulguerov; Jelena Todic; Marc Pusztaszeri; Naif H Alotaibi
Journal:  Front Surg       Date:  2017-05-15

3.  Salivary Gland Pleomorphic Adenomas Presenting With Extremely Varied Clinical Courses. A Single Institution Case-Control Study.

Authors:  Krzysztof Piwowarczyk; Ewelina Bartkowiak; Paweł Kosikowski; Jadzia Tin-Tsen Chou; Małgorzata Wierzbicka
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

4.  Clinical manifestations of recurrent parotid pleomorphic adenoma.

Authors:  Myung-Whan Suh; J Hun Hah; Seong Keun Kwon; Young-Ho Jung; Tack-Kyun Kwon; Kwang Hyun Kim; Myung-Whun Sung
Journal:  Clin Exp Otorhinolaryngol       Date:  2009-12-31       Impact factor: 3.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.